Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Unknown 2Completed 2

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2

Conditions

Leukemia 14Leukemia, Myeloid, Acute 9Congenital Abnormalities 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Myelodysplastic Syndromes 5Leukemia, Myelomonocytic, Chronic 5Myeloproliferative Disorders 4Multiple Myeloma 4Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Leukemia, Lymphocytic, Chronic, B-Cell 4Anemia, Refractory, with Excess of Blasts 4Leukemia, Monocytic, Acute 3Leukemia, Megakaryoblastic, Acute 3Leukemia, Erythroblastic, Acute 3Blast Crisis 3Waldenstrom Macroglobulinemia 2Thrombocythemia, Essential 2Squamous Cell Carcinoma of Head and Neck 2Precancerous Conditions 2Polycythemia Vera 2Neoplasms, Plasma Cell 2Myelodysplastic-Myeloproliferative Diseases 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma, Non-Hodgkin 2Lymphoma, Mantle-Cell 2Lymphoma, Large-Cell, Immunoblastic 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Prolymphocytic 2

Interventions

Imatinib Mesylate 86nilotinib 59fludarabine phosphate 46Cyclophosphamide 45Mycophenolic Acid 37Whole-Body Irradiation 35Dasatinib 32fludarabine 31Tacrolimus 29Cyclosporine 24Busulfan 23Peripheral Blood Stem Cell Transplantation 22Methotrexate 20bosutinib 18Cytarabine 18Granulocyte Colony-Stimulating Factor 16Filgrastim 16Melphalan 14thymoglobulin 13Antilymphocyte Serum 13Stem Cell Transplantation 12sargramostim 11Thiotepa 11Interferon-alpha 10Cord Blood Stem Cell Transplantation 9asciminib 8Cyclosporins 8ponatinib 7Sirolimus 7Radiotherapy 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myelogenous, Chronic, BCR-ABL Positive × Cytogenetic Analysis × Clear all
NCT00769327 2022-01-04

CML0408

Gruppo Italiano Malattie EMatologiche dell'Adulto

Phase 2 Completed
129 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

NCT00809211 2018-07-24

Nilotinib in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia

Cancer Trials Ireland

Phase 2 Completed
40 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡